Mahaifa dysplasia

Dysplasia na mahaifa yana nufin canje-canje mara kyau a cikin ƙwayoyin akan farfajiyar wuyan mahaifa. Mahaifa shine ƙananan ɓangaren mahaifar (mahaifar) wanda ke buɗewa a saman farjin mace.

Sauye-sauyen ba ciwon daji bane amma suna iya haifar da cutar kansa ta mahaifar mahaifa idan ba ayi magani ba.

Cutar sankarar mahaifa na iya bunkasa a kowane zamani. Koyaya, bibiya da magani zai dogara ne akan shekarun ku. Cutar sankarau ta mahaifa galibi sanadin ta papillomavirus ne (HPV) na mutum. HPV cuta ce ta gama gari wacce ke yaduwa ta hanyar jima'i. Akwai nau'ikan HPV da yawa. Wasu nau'ikan suna haifar da dysplasia na mahaifa ko ciwon daji. Sauran nau'ikan HPV na iya haifar da cututtukan al'aura.

Abubuwan da ke gaba na iya ƙara yawan haɗarinku ga cutar dansplasia ta mahaifa:

• Yin jima'i kafin shekaru 18
• Samun ɗa tun yana ƙarami
• Bayan sun sami abokan jima'i da yawa
• Samun wasu cututtuka, kamar tarin fuka ko HIV
• Amfani da magunguna masu danne garkuwar ku
• Shan taba
• Tarihin uwa game da bayyanar DES (diethylstilbestrol)

Yawancin lokaci, babu alamun bayyanar.

Mai ba da lafiyar ku zai yi gwajin kwalliya don duba cutar sankarar mahaifa. Gwajin farko yawanci gwajin Pap ne da gwajin kasancewar HPV.

Cerp dysplasia wanda aka gani akan gwajin Pap ana kiran shi squamous intraepithelial lesion (SIL). A kan rahoton gwajin Pap, waɗannan canje-canje za a bayyana su:

• -Ananan daraja (LSIL)
• Babban-aji (HSIL)
• Yiwuwar cutar kansa (m)
• Kwayoyin glandular atypical (AGC)
• Cellsananan ƙwayoyin ƙwayoyin cuta (ASC)

Kuna buƙatar ƙarin gwaje-gwaje idan gwajin Pap ya nuna ƙwayoyin mahaukaci ko dysplasia na mahaifa. Idan canje-canjen basu da sauki, gwajin Pap na iya zama abin da ake buƙata.

Mai bayarwa na iya yin biopsy don tabbatar da yanayin. Ana iya yin wannan tare da amfani da colposcopy. Duk wani yanki na damuwa zai zama biopsied. Abubuwan da ke tattare da kwayar halitta ba su da yawa kuma yawancin mata suna jin karamin mahimmin ciki.

Dysplasia wanda ake gani akan kwayar halittar mahaifa ana kiransa cervical intraepithelial neoplasia (CIN). An haɗe shi zuwa nau'ikan 3:

• CIN I - m dysplasia
• CIN II - matsakaici zuwa alamar dysplasia
• CIN III - mummunan dysplasia zuwa carcinoma a cikin yanayi

Wasu nau'ikan HPV sanannu ne da ke haifar da sankarar mahaifa. Gwajin DNA na HPV na iya gano nau'ikan haɗarin HPV masu haɗari da wannan ciwon daji. Ana iya yin wannan gwajin:

• A matsayin gwajin nunawa ga mata sama da shekaru 30
• Ga mata na kowane zamani da ke da ɗan sakamako mara kyau na gwajin Pap

Jiyya ya dogara da digirin dysplasia. Dysplasia mai sauki (LSIL ko CIN I) na iya tafiya ba tare da magani ba.

• Kila kawai buƙatar mai kulawa ta hanyar kulawa tare da maimaita gwajin Pap kowane watanni 6 zuwa 12.
• Idan canje-canjen basu tafi ba ko suka kara muni, ana bukatar magani.

Jiyya don dysplasia mai matsakaici-zuwa-mai tsanani ko mara ƙarfi mai rauni wanda ba zai tafi ba na iya haɗawa da:

• Yin aikin tiyata don daskare ƙwayoyin ƙwayoyin cuta
• Laser far, wanda yayi amfani da haske don ƙone nama mara kyau
• LEEP (hanyar madaidaiciyar fitowar lantarki), wanda ke amfani da wutar lantarki don cire ƙwayar cuta
• Tiyata don cire ƙwayar mahaukaci (bioe biopsy)
• Hysterectomy (a cikin ƙananan lokuta)

Idan kuna da cutar dysplasia, kuna buƙatar maimaita gwaji kowane watanni 12 ko kamar yadda mai ba da sabis ya ba da shawara.

Tabbatar samun rigakafin HPV lokacin da aka gabatar muku. Wannan allurar rigakafin tana hana kansar mahaifa da yawa.

Ganowar farko da magani na gaggawa yana warkar da mafi yawan cututtukan dysplasia na mahaifa. Koyaya, yanayin na iya dawowa.

Ba tare da magani ba, mummunan dysplasia na mahaifa na iya canzawa zuwa cutar sankarar mahaifa.

Kirawo mai ba ka sabis idan shekarunku sun kai 21 ko sama da haka kuma ba ku taɓa yin gwajin ƙashin ƙugu da gwajin Pap ba.

Tambayi mai ba ku sabis game da rigakafin HPV. 'Yan matan da suka karbi wannan allurar kafin su fara jima'i suna rage damar kamuwa da cutar sankarar mahaifa.

Zaka iya rage haɗarin kamuwa da cutar sankarau ta mahaifa ta hanyar ɗaukar waɗannan matakan:

• Yi rigakafi don HPV tsakanin shekaru 9 zuwa 45.
• Kar a sha taba. Shan sigari yana kara kasadar kamuwa da cutar dysplasia mai matukar wahala da cutar kansa.
• Kada ku yi jima'i har sai kun kasance 18 ko tsufa.
• Yi aikin jima'i lafiya. Yi amfani da robaron roba.
• Aiwatar da auren mata daya. Wannan yana nufin kuna da abokin tarayya ɗaya kawai a lokaci guda.

Cervical intraepithelial neoplasia - dysplasia; CIN - dysplasia; Canje-canjen da suka gabata na mahaifa - dysplasia; Ciwon sankarar mahaifa - dysplasia; Raunin intraepithelial na squamous - dysplasia; LSIL - dysplasia; HSIL - dysplasia; Pananan dysplasia; Babban-dysplasia; Carcinoma a cikin wuri - dysplasia; CIS - dysplasia; ASCUS - dysplasia; Kwayoyin glandular atypical - dysplasia; AGUS - dysplasia; Cellsananan ƙwayoyin ƙwayoyin cuta - dysplasia; Pap shafa - dysplasia; HPV - dysplasia; Kwayar cutar papilloma na mutum - dysplasia; Cervix - dysplasia; Kwayar cuta - dysplasia

• Tsarin haihuwa na mata
• Neoplasia na mahaifa
• Mahaifa
• Cervical dysplasia - jerin

Kwalejin likitan haihuwa ta Amurka da na mata. Aiki Bulletin A'a. 168: binciken kansar mahaifa da rigakafin ta. Obstet Gynecol. 2016; 128 (4): e111-e130. PMID: 27661651 pubmed.ncbi.nlm.nih.gov/27661651/.

Kwalejin likitan haihuwa ta Amurka da na mata. Yi Aikin Sanarwa A'a. 140: gudanar da sakamakon gwajin cututtukan sankarar mahaifa da ƙananan maganan kansar mahaifa. Obstet Gynecol. 2013; 122 (6): 1338-1367. PMID: 24264713 pubmed.ncbi.nlm.nih.gov/24264713/.

Armstrong DK. Ciwon cututtukan mata. A cikin: Goldman L, Schafer AI, eds. Magungunan Goldman-Cecil. 26th ed. Philadelphia, PA: Elsevier; 2020: babi na 189.

Freedman MS, Hunter P, Ault K, Kroger A. Kwamitin Shawara kan Ayyukan Allurar rigakafi ya ba da shawarar jadawalin rigakafin ga manya masu shekaru 19 ko sama da haka - Amurka, 2020. MMWR Morb Mutuwa Wkly Rep. 2020; 69 (5): 133-135. PMID: 32027627 pubmed.ncbi.nlm.nih.gov/32027627/.

Dan Dandatsa NF. Cutar sankarar mahaifa da cutar daji. A cikin: Hacker NF, Gambone JC, Hobel CJ, eds. Mahimmancin Hacker & Moore na Obstetrics and Gynecology. Na 6 ed. Philadelphia, PA: Elsevier; 2016: babi na 38.

Rukuni na Kwararrun Masana rigakafi, Kwamitin Kula da Kiwon Lafiyar Yara. Bayanin Kwamitin A'a. 704: rigakafin cutar papillomavirus ta mutum. Obstet Gynecol. 2017; 129 (6): e173-e178. PMID: 28346275 pubmed.ncbi.nlm.nih.gov/28346275/.

Robinson CL, Bernstein H, Poehling K, Romero JR, Szilagyi P. Kwamitin Shawara kan Aiwatar da Alluran rigakafi Ya ba da shawarar jadawalin rigakafin yara da matasa masu shekaru 18 ko ƙarami - Amurka, 2020. MMWR Morb Mutuwa Wkly Rep. 2020; 69 (5): 130-132. PMID: 32027628 pubmed.ncbi.nlm.nih.gov/32027628/.

MP Salcedo, Baker ES, Schmeler KM. Intraepithelial neoplasia na ƙananan al'aura (cervix, farji, vulva): ilimin halittar jiki, bincike, ganewar asali, gudanarwa. A cikin: Lobo RA, Gershenson DM, Lentz GM, Valea FA, eds. M Gynecology. 7th ed. Philadelphia, PA: Elsevier; 2017: babi na 28.

Saslow D, Solomon D, Lawson HW, et al; ACS-ASCCP-ASCP Kwamitin Jagorancin Ciwon Mara na Ciwon Mara. American Cancer Society, American Society for Colposcopy da mahaifa Pathology, kuma American Society for Clinical Pathology nunawa jagororin domin yin rigakafi da farkon gano cutar sankarar mahaifa. CA Ciwon daji J Clin. 2012; 62 (3): 147-172. PMID: 22422631 pubmed.ncbi.nlm.nih.gov/22422631/.

Servicesungiyar Ayyuka na Rigakafin Amurka, Curry SJ, Krist AH, Owens DK, et al. Nunawa game da cutar sankarar mahaifa: Sanarwar shawarar Tasungiyar kungiyar Ayyuka ta Amurka. JAMA. 2018; 320 (7): 674-686. PMID: 30140884 pubmed.ncbi.nlm.nih.gov/30140884/.